Dexmedetomidine promotes cell proliferation and inhibits cell apoptosis by regulating LINC00982 and activating the phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT) signaling in hypoxia/reoxygenation-induced H9c2 cells

Previous studies showed dexmedetomidine (DEX) could alleviate myocardial ischemia/reperfusion injury (MIRI). Nevertheless, the mechanisms by which DEX alleviated MIRI remain to be determined. Our results demonstrated that DEX reversed hypoxia/reoxygenation (H/R)-induced decreased proliferation, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Li, Zhen, Xia, Shuyun, Xu, Zhixin, Chen, Xiaofang, Sun, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161950/
https://www.ncbi.nlm.nih.gov/pubmed/35466860
http://dx.doi.org/10.1080/21655979.2022.2060900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161950/
https://www.ncbi.nlm.nih.gov/pubmed/35466860
http://dx.doi.org/10.1080/21655979.2022.2060900

Ejemplares similares